SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-118069
Filing Date
2024-04-26
Accepted
2024-04-26 16:13:56
Documents
9
Period of Report
2024-05-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d674951ddef14a.htm DEF 14A 537040
2 GRAPHIC g674951g01a01.jpg GRAPHIC 37467
3 GRAPHIC g674951g01t01.jpg GRAPHIC 439360
4 GRAPHIC g674951g01t02.jpg GRAPHIC 257633
5 GRAPHIC g674951g06a06.jpg GRAPHIC 55920
6 GRAPHIC g674951g13j07.jpg GRAPHIC 17377
7 GRAPHIC g674951g51w01.jpg GRAPHIC 53138
8 GRAPHIC g674951g73l41.jpg GRAPHIC 60831
9 GRAPHIC g674951g90t91.jpg GRAPHIC 23079
  Complete submission text file 0001193125-24-118069.txt   1840577
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39659 | Film No.: 24883913
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)